Including the studies that found nothingFree guidesProducts with the evidence attachedFree researchSlow down how fast you ageFree knowledge for everyone
Kratos Natural

Red and near-infrared light: a 2,225-study search

Author: Liam Kratos | Published: | Updated:

Sources: 2225 PubMed studies | Cited here: 64 human studies | 9 min read

Red and near-infrared light across skin, pain, cognition, mood and eye safety, with a transparent count of how many studies were actually verified.

How it is supposed to work

The whole field rests on one proposed mechanism, and it is worth knowing because it explains why the same narrow band of wavelengths keeps reappearing.

Red and near-infrared light between roughly 660 and 830 nanometres passes through skin to a limited depth and is absorbed by cytochrome c oxidase, an enzyme in the mitochondria. The proposal is that this displaces nitric oxide bound to the enzyme, the respiratory chain speeds up, and the cell produces more ATP. Everything else claimed for this light, in wounds, in muscle, in the brain, is downstream of that single step.

It also explains the dose curve. If the mechanism is enzymatic, more light is not more effect, and past a point it becomes less.

How was this article built?

Rather than write about one supplement or one claim, we set out to answer a bigger question. Across everything published about red and near-infrared light, what does the evidence actually show, the good and the bad?

We searched PubMed systematically across nine domains (skin, musculoskeletal pain, mitochondrial function and aging, mood and mental health, hair growth, sleep, eye safety, and general device/wavelength parameters), collecting systematic reviews, meta-analyses, and reviews. After removing duplicates across domains, this left 2,225 unique studies.

What the 2,225 studies narrowed down to:

  • 2,225 unique studies collected across all 9 domains.
  • A title-level screen (checking for light/laser/photobiomodulation-related terms, and separately for eye-safety-relevant "light exposure/damage" language) narrowed this to 1,250 studies plausibly relevant to light therapy. The remaining 975 were excluded as clearly off-topic (for example, "alopecia" appearing only as an unrelated drug side effect).
  • As of this version, we have read all eight domains to completion or the point of diminishing returns (Sleep: 17/17, Mitochondria/Aging: 62/62, Hair growth: 42/42, Other/General mechanism: 77/77, Eye safety, Skin, Musculoskeletal/Pain, and Device/wavelength specs all substantially reviewed). That's roughly 430 studies read and verified in full.
  • This produced 63 individually verified findings, cited throughout this article.

That means the large majority of the 1,250 title-screened studies have not yet been individually read. This is not a completed systematic review of "all research on infrared light." It's a transparent, continuously-updated verification effort, published at its current stage of progress rather than held back until finished. We name this plainly because the alternative, implying more thoroughness than actually exists, is exactly the kind of small dishonesty we've committed to avoiding.

Which wavelength works, and at what dose?

The clearest pattern across independent domains is this: red to early near-infrared light (roughly 660-830nm), delivered at relatively low doses (roughly 3-12 J/cm²), shows up repeatedly as the range associated with positive outcomes. Not in one study, but across several unrelated fields of research.

  • In wound healing, randomized controlled trials in oral surgery found 660-810nm at 3-12 J/cm² associated with better epithelialization, reduced inflammatory markers (TNF-α, IL-6), and increased VEGF [2][3].
  • In diabetic foot ulcers, 632.8-685nm at 3-6 J/cm² produced a significant reduction in ulcer size [4].
  • In carpal tunnel syndrome, while overall evidence was judged not strong, protocols using 780-860nm at 9-11 J/cm² specifically showed more favorable outcomes [16].
  • In an animal spinal cord injury model, wavelengths under 700nm were associated with better locomotor recovery than longer wavelengths [5].

These are mostly modest-sized trials, heterogeneous in design. This pattern is a reasonable, evidence-informed starting point. It is not proof that any specific consumer device will replicate clinical results.

Does infrared light heal wounds?

Its own piece: Does red light help wounds heal?, with the search strategy across 390 studies.

The short version. It depends on the wound, more sharply than you would expect. In diabetic foot ulcers light nearly doubles the chance of healing (risk ratio 1.93 across 28 trials). In venous leg ulcers, a wound that looks similar from the outside, there is no significant effect. In burns two meta-analyses contradict each other and the work is largely in animals.

An audit of the literature pointed at the likely cause of all that contradiction: measuring and reporting the light dose itself is done poorly, so two reviews of the same intervention may in fact be about different treatments.

Does infrared light help your memory?

Its own piece: Red light and your brain, with the search strategy across 81 studies.

The short version. Several independent meta-analyses find improved cognitive function in older adults, with effect sizes around SMD 0.51 to 0.63, and in a network meta-analysis of 38 studies light ranked first among non-pharmacological interventions for dementia. The caveat that used to sit here, that home devices did not reach significance, has been overtaken by a 2026 randomised trial in which MoCA scores at home rose by 3.87 points while the placebo group fell.

The other side is stated too: that trial and its forerunner come from the same group with the same device, so independent replication is still missing.

Does red light help with mood?

A PROSPERO-registered meta-analysis of RCTs found photobiomodulation significantly reduced depression symptoms (SMD −0.55, 95% CI −0.75 to −0.35) [7]. Best-performing protocols: 823nm (transcranial, 10-100 J/cm²) or 808nm (systemic, ≤1 J/cm²).

The honest part: the same meta-analysis found no statistically significant effect on sleep outcomes specifically (SMD −0.82, 95% CI −2.41 to 0.77, p > 0.05), despite sleep being an explicitly measured secondary outcome, and rated overall certainty as low to very low. A separate review suggested different "best" parameters entirely (810nm for depression, 1064nm for cognitive enhancement, at a much higher 250 mW/cm² irradiance) [8]. This field has genuine disagreement about optimal parameters, not settled consensus.

Is infrared light bad for your eyes?

This part has grown large enough to have its own piece: Is red light bad for your eyes?, with its own search strategy across 488 studies.

The short version. Red light shone into the eye has been studied in thousands of children as a treatment for myopia, across 28 randomised trials, and it outperformed the established treatments. The safety review covering 1,436 treated children reported no permanent vision loss, but no study ran longer than two years.

The cases of lasting eye damage that do exist come not from therapy lamps but from staring into an infrared heat lamp and from a laser pointer. The difference lies in wavelength, duration, and whether the light hangs diffusely in a room or enters the pupil as a beam. Which is why "do not look directly into the light" is not boilerplate but an instruction with documented cases behind it.

The safety questions around cancer and DNA, which used to sit in this section, now have their own piece: Is light therapy safe if you have or have had cancer?. The short version: the clinical evidence is reassuring, the cell culture work is not uniformly so, and the question that matters most to survivors has never been studied directly.

Why do single studies look better than the pooled result?

A PROSPERO-registered meta-analysis of animal fracture healing studies found that most individual studies reported a positive effect, but the pooled meta-analysis found no significant effect on maximum fracture force or bone mineralization [15]. The most common wavelengths were 780nm, 808nm, and 830nm, the same range showing up elsewhere in this article, yet the aggregated result was null.

This pattern repeats: a meta-analysis found no significant clinical benefit of photobiomodulation for age-related macular degeneration (visual acuity, drusen volume, geographic atrophy all non-significant) [23]. Of 14 animal studies on cardiac remodeling after heart attack, three found no effect on infarct size and only one found a positive effect overall [24]. An 18-RCT meta-analysis (793 participants) found infrared laser may not be superior to sham for rheumatoid arthritis pain, stiffness, or function [30]. A PROSPERO-registered meta-analysis for Type 2 diabetes found primary metabolic and neurological outcomes too heterogeneous to even statistically pool, with the only measurable effect (on secondary periodontal outcomes) explicitly described by the researchers as "unlikely to be clinically meaningful in isolation" [25]. And a PROSPERO-registered review of energy-based devices for post-episiotomy healing found infrared reduced pain but not healing, while low-level laser therapy improved neither [31].

Whenever this article cites a meta-analysis over an individual study, this is why: individual studies can report encouraging results that don't survive pooled statistical scrutiny.

Is red light the same as infrared?

Most of this article converges on 660-830nm. There is one clear exception. A review of 22 clinical trials found the longer wavelength of 1064nm produced a very large effect size for knee osteoarthritis pain (Cohen's d = 2.46), using high-powered laser protocols [32]. That is a long way from what converges for skin or for cognition. A deep joint may want its own parameters, rather than one wavelength serving every purpose.

Does infrared light help muscle and joint pain?

This part has its own piece too: Does red light work for pain?, with the search strategy across 412 systematic reviews.

The short version. There are 412 reviews on light and pain, and they contradict each other: for knee osteoarthritis two meta-analyses reach opposite conclusions. Cochrane concluded on carpal tunnel syndrome that there are no data supporting any clinical effect. And an umbrella review scored the quality of twenty reviews in this field at an average of 12.9 on AMSTAR-2, so the label systematic review guarantees nothing here.

Where an effect is found it is almost always on pain and almost never on function. In the newest review, not one participant received the laser on its own: every trial gave it alongside exercise.

Does infrared light improve your sleep?

Separately from our formally registered PROSPERO systematic review on infrared light and sleep (in progress), we found a dedicated systematic review and meta-analysis on exactly this question: five RCTs, 240 participants, searched through September 2025 [26]. Photobiomodulation improved Pittsburgh Sleep Quality Index scores (MD −1.25, 95% CI −2.38 to −0.11, p=0.03), but the authors themselves noted the wide confidence interval reflects limited precision.

A separate, smaller review of whole-body photobiomodulation found a similarly honest split: of five studies, two reported better sleep quality (including higher melatonin and lower nocturnal heart rate), but none of the five found any benefit for exercise recovery or performance [27]. A sleep benefit doesn't necessarily extend to other claims often marketed alongside it.

How was the research selected?

This article draws from a structured, multi-domain PubMed search yielding 2,225 unique studies after deduplication, narrowed to 1,250 after title-level screening. All eight domains have been read fully, substantially, or to the point of diminishing returns: sleep, mitochondria and aging, hair growth, general mechanism, eye safety, skin, musculoskeletal pain, and device and wavelength specifications. That is roughly 430 studies read and verified in full, producing 63 individually verified findings.

This is still not a completed systematic review of "all research on infrared light" in the strictest sense. Several hundred title-screened studies in the largest domains were deliberately not read in depth. Most of them were dental and orthodontic, which recurred heavily across the musculoskeletal and device-parameter searches. They bear little on general wellness use, and they echoed findings already verified here closely enough that reading them would not have moved the picture. That selection criterion is itself worth naming as a limitation: studies precise enough to report exact parameters, or registered on PROSPERO/Cochrane, may differ systematically from the broader literature, and we prioritized exactly those studies.

This article does not constitute a formal systematic review or meta-analysis in its own right. It synthesizes and verifies findings from existing systematic reviews and meta-analyses, clearly citing each one. A separate, formally registered (PROSPERO) systematic review focused specifically on infrared light and sleep is in progress and will be published separately with full methodological rigor. Readers should treat this article as a thorough, transparent, current best-effort synthesis, not a final, unchangeable word on a rapidly growing research field.

Sources

  1. 1.Maghfour J, Mineroff J, Ozog DM. Evidence-based consensus on the clinical application of photobiomodulation. J Am Acad Dermatol. 2025. PMID: 40253006
  2. 2.Systematic review of randomized controlled trials on low-level laser therapy in oral surgery, evaluating wound healing, pain, and inflammation outcomes. PMID: 40288479
  3. 3.Commentary on the above oral surgery systematic review, discussing risk-of-bias and certainty of evidence. PMID: 41578029
  4. 4.Systematic review and meta-analysis of low-level laser therapy for diabetic foot ulcer healing. PMID: 32394760
  5. 5.Systematic review and meta-analysis of low-level laser therapy on pathophysiology and locomotor recovery after traumatic spinal cord injury in animal models. PMID: 33791887
  6. 6.Systematic review of human studies on transcranial photobiomodulation and cognitive function. PMID: 36371017
  7. 7.Systematic review and meta-analysis of randomized controlled trials on photobiomodulation for depression symptoms, PROSPERO-registered (CRD42023444677). PMID: 38356614
  8. 8.Systematic review of photobiomodulation as a tool in the management of psychological disorders. PMID: 33069687
  9. 9.Systematic review of in vitro studies on photobiomodulation effects on periodontal ligament stem cells. PMID: 35638280
  10. 10.Primary study on photobiomodulation preserving mitochondrial redox state and retinal structure in a rodent model of retinitis pigmentosa. PMID: 33230161
  11. 11.Primary study on 670nm light mitigating oxygen-induced degeneration in mouse retina. PMID: 24134095
  12. 12.Primary study comparing dietary saffron and photobiomodulation as neuroprotectants in a rat retinal light-damage model. PMID: 24093084
  13. 13.Primary study on near-infrared irradiation upregulating EGFR expression in reconstructed human corneal epithelial tissue, simulating solar NIR exposure. PMID: 27536083
  14. 14.Systematic review of transcranial photobiomodulation effects on cerebral circulation and brain neural oscillations, PROSPERO-registered (CRD42023393544), Cochrane RoB2-assessed. PMID: 40844561
  15. 15.Systematic review and meta-analysis of photobiomodulation therapy on fracture healing in animal studies, PROSPERO-registered (CRD42024514398). PMID: 40016554
  16. 16.Systematic review of low-level laser therapy on pain, hand function, and grip strength in carpal tunnel syndrome. PMID: 28272964
  17. 17.Systematic review and meta-analysis on the best parameters of low-level laser therapy for orofacial pain, GRADE-assessed. PMID: 36263978
  18. 18.Systematic review and meta-analysis of photobiomodulation for age-related cognitive impairment, PROSPERO-registered (CRD42022374562), 11 RCTs. PMID: 37843594
  19. 19.Review of light parameters and photobiomodulation efficacy across tissues with differing mitochondrial density. PMID: 30550048
  20. 20.Systematic review and meta-analysis of photobiomodulation for cognitive deficits in Alzheimer's disease animal models. PMID: 41761363
  21. 21.Systematic review and meta-analysis of phototherapy for cognitive function in patients with dementia, PROSPERO-registered (CRD42021267596). PMID: 35847661
  22. 22.Network meta-analysis comparing non-pharmacological therapies, including photobiomodulation, for cognitive function in dementia, PROSPERO-registered (CRD42022363746). PMID: 36967820
  23. 23.Systematic review and meta-analysis of photobiomodulation for age-related macular degeneration. PMID: 40089957
  24. 24.Systematic review of experimental studies on low-level laser therapy for cardiac remodeling after myocardial infarction. PMID: 26930372
  25. 25.Systematic review and meta-analysis of photobiomodulation for metabolic, inflammatory, and neurological outcomes in Type 2 diabetes, PROSPERO-registered (CRD420251083550). PMID: 41516314
  26. 26.Systematic review and meta-analysis of photobiomodulation and sleep quality. PMID: 42322437
  27. 27.Systematic review of whole-body photobiomodulation for exercise performance and recovery. PMID: 39883205
  28. 28.Focused systematic review of the oncologic safety of low-level light therapy for aesthetic skin rejuvenation. PMID: 36722207
  29. 29.Systematic literature review of therapeutic efficacy of home-use photobiomodulation devices. PMID: 31050938
  30. 30.Systematic review and meta-analysis of low-level laser therapy in adults with rheumatoid arthritis. PMID: 37683021
  31. 31.Systematic review and meta-analysis of energy-based devices for episiotomy pain and healing, PROSPERO-registered (CRD42024608543). PMID: 41450164
  32. 32.Systematic review and meta-analysis of the 1064nm wavelength in photobiomodulation for musculoskeletal conditions. PMID: 35155171
  33. 33.Primary study on ocular temperature elevation from threshold 1090nm infrared radiation exposure and associated cataract induction. PMID: 25321397
  34. 34.Review of photobiomodulation in ocular therapy, current status and future perspectives. PMID: 39967973
  35. 35.Primary study on prolonged deep red light photobiomodulation in a mouse model of type 2 diabetes retinal deterioration. PMID: 39596197
  36. 36.Clinical case study of maculopathy following exposure to visible and infrared radiation from a laser pointer. PMID: 26921203
  37. 37.Clinical case report of phototoxic maculopathy induced by quartz infrared heat lamp. PMID: 28099337
  38. 38.Primary study on retinal damage induced by visible blue and near-infrared light of an operating microscope. PMID: 1414701
  39. 39.Primary study on near-infrared light protecting photoreceptors from light-induced damage in rats, at varying ambient illumination levels. PMID: 20238037
  40. 40.Primary dose-response study establishing the safety profile of slit-lamp-delivered retinal laser photobiomodulation. PMID: 32818109
  41. 41.Review of biohazards from ultraviolet, visible, and infrared radiation to the eye. PMID: 6842311
  42. 42.Assessment of the optical radiation hazard from a home-use intense pulsed light (IPL) source. PMID: 19639624
  43. 43.Randomized controlled trial of far infrared radiation therapy for gynecological cancer-related lymphedema, including oncologic safety testing. PMID: 34028298
  44. 44.Systematic review of the safety and efficacy of photobiomodulation therapy in oncology, 67 studies. PMID: 33107198
  45. 45.Systematic review of low-level laser therapy effects on cancer cells in vitro. PMID: 31209588
  46. 46.Systematic review examining tumor-modulating effects of photobiomodulation therapy on head and neck squamous cell carcinoma cells. PMID: 31197302
  47. 47.Systematic review of low-level laser therapy in secondary lymphedema after breast cancer. PMID: 23192573
  48. 48.Overview and update of systematic reviews on the effectiveness and safety of low-level laser therapy for breast cancer-related lymphedema. PMID: 34779937
  49. 49.Systematic review and meta-analysis of red and infrared light as adjunctive treatment for diabetic foot ulcers. PMID: 39305794
  50. 50.Systematic review and meta-analysis of photobiomodulation therapy for the prevention of acute radiation dermatitis. PMID: 36952036
  51. 51.Systematic review and meta-analysis of the healing effect of photobiomodulation on venous leg ulcers. PMID: 41889013
  52. 52.Systematic review and meta-analysis of photobiomodulation therapy in burn wound healing, preclinical studies. PMID: 34264767
  53. 53.Systematic review and meta-analysis of photobiomodulation in burn wounds, clinical and preclinical studies. PMID: 39172550
  54. 54.Systematic review auditing light-measurement reporting practices in low-level light therapy literature. PMID: 26964800
  55. 55.Cochrane systematic review of low-level laser therapy for carpal tunnel syndrome. PMID: 35611937
  56. 56.Systematic review and network meta-analysis of low-level laser therapy for carpal tunnel syndrome, PROSPERO-registered (CRD42017082650). PMID: 32026843
  57. 57.Systematic review and meta-analysis of low-level laser therapy dose-response on pain and disability in knee osteoarthritis, PROSPERO-registered (CRD42016035587). PMID: 31662383
  58. 58.Systematic review and meta-analysis of low-level laser therapy for neck pain. PMID: 19913903
  59. 59.Umbrella review assessing the methodological quality of systematic reviews on high-intensity laser therapy for musculoskeletal pain. PMID: 39652213
  60. 60.Meta-analysis of low-level laser therapy effects on muscular performance and soreness recovery in athletes. PMID: 34428975
  61. 61.Systematic review and network meta-analysis comparing high-intensity and low-level laser therapy combined with exercise for knee osteoarthritis. PMID: 39193110
  62. 62.Systematic review and meta-analysis of low-level laser therapy for knee osteoarthritis, 9 RCTs totalling 518 patients. PMID: 25914044
  63. 63.Gam AN, Thorsen H, Lonnberg F. The effect of low-level laser therapy on musculoskeletal pain: a meta-analysis. Pain. 1993. PMID: 8446437
  64. 64.Systematic review of low-level laser therapy for breast cancer-related lymphedema, PROSPERO-registered (CRD42022315076). PMID: 36042421

Free longevity guide

Kratos Weekly lands in your inbox every Monday to start your week with: the latest analysis of that week's research, a recipe, a workout, a song with an explanation, a poem, and whatever else is worth passing on.

We store your email address to send the newsletter. Unsubscribe in one click, any time.